EuroQol

We are involved in several EuroQol-funded projects. As well as jointly overseeing and advising on the new UK EQ-5D-5L valuation study, and contributing to the development of the new EQ-HWB instrument, we are participating in a number of research studies seeking to improve methods for measuring and valuing health-related quality of life.

Visit the EuroQol website.

Medical Research Council: Better Methods, Better Research (BMBR) panel

The Better Methods, Better Research (BMBR) panel is a partnership co-funded by the Medical Research Council (MRC) and the Department of Health and Social Care’s National Institute for Health and Care Research (NIHR). The aim of BMBR is to ensure, via provision of funding, that optimal research methods are being used to advance biomedical-, health- and care-related research and policies. NICE has an advisory role at panel meetings, highlighting proposals of interest that align with our methods research areas or address current methodological challenges in guideline development.

NICE can partner with researchers applying for funding from the MRC BMBR panel in several ways. Find out more about partnering with us for research.

Visit the UK Research and Innovation website to find out more.

National Institute for Health and Care Research (NIHR)

NICE meets regularly with NIHR to share information about our respective research priorities, and seeks NIHR’s input to ensure our research recommendations are clear and actionable. We also work closely to fast-track, co-produce and advertise research briefs which are jointly agreed as key priorities. In addition to these fast-tracked key priorities, NIHR also reviews all NICE guidance and advertises research calls against NICE research recommendations through individual programme commissioned workstreams. NIHR has been screening NICE guidance for nearly 20 years to identify topics suitable for commissioning research. In 2021, NIHR launched a researcher-led rolling funding call, which will complement existing commissioning workstreams. The rolling research call aims to build on the success of the relationship between NIHR and NICE, and further develop the evidence base supporting guidance development.

Visit the NIHR website.

New Drug Development Paradigms (NEWDIGS) programme

NICE is part of a global group of organisations who want to speed up the development and delivery of new, effective and affordable drugs.

The programme brings together pharmaceutical companies, academic researchers, patient advocacy groups, government agencies and other experts.

Find out more about the NEWDIGS programme.